U.S. Healthtech Stock News

NYSE:ALL
NYSE:ALLInsurance

Assessing Allstate (ALL) Valuation After Recent Choppy Trading And Long Term Shareholder Returns

Allstate (ALL) is back in focus after recent share moves, with the stock closing at $205.03. Investors are weighing this price against the insurer’s earnings profile and its current value score of 5. See our latest analysis for Allstate. Recent trading has been a bit choppy, with a 7 day share price return of 3.11% and a 90 day share price return of 1.04%. At the same time, Allstate’s 3 year total shareholder return of 95.84% and 5 year total shareholder return of 99.35% reflect a very strong...
NasdaqGM:CRVS
NasdaqGM:CRVSBiotechs

Corvus Trials Progress And Cash Raise Reframe Soquelitinib Risk Reward Profile

Corvus Pharmaceuticals has moved its lead candidate, soquelitinib, into late-stage Phase 3 and Phase 2 trials across several indications. The company raised $189 million in a follow-on offering, which it says extends its cash runway into 2028. Corvus Pharmaceuticals (NasdaqGM:CRVS) is drawing attention after pushing soquelitinib into more advanced clinical trials while securing fresh capital to support the work. The stock trades at $16.01, with very large 3-year and 1-year returns, and a...
NasdaqGM:EH
NasdaqGM:EHAerospace & Defense

A Look At EHang Holdings (NasdaqGM:EH) Valuation After A Swing To Q4 Net Income

Why EHang’s latest earnings matter for shareholders EHang Holdings (NasdaqGM:EH) just reported its Q4 and full year 2025 results, highlighted by a move to net income in the quarter after a net loss in the prior year period. Fourth quarter sales were CNY 243.78 million compared with CNY 164.28 million a year earlier, with net income of CNY 10.49 million replacing a CNY 46.86 million net loss, and basic earnings per share reaching CNY 0.14. See our latest analysis for EHang Holdings. The share...
NYSE:DOCN
NYSE:DOCNIT

Why DigitalOcean Holdings (DOCN) Is Up 23.0% After Powering Workato’s Next-Gen Enterprise AI Agents

In early March 2026, DigitalOcean announced that Workato’s AI Research Lab had shifted its next-generation enterprise AI agents to DigitalOcean’s vertically integrated, inference-optimized platform powered by NVIDIA Hopper GPUs, achieving faster time-to-first-token, higher throughput, and lower costs for complex, reasoning-heavy workloads like Llama-3.3-70B under real production conditions. By co-designing a distributed inference architecture on DigitalOcean Kubernetes and using NVIDIA...
NYSE:BA
NYSE:BAAerospace & Defense

Boeing’s Israel Bomb Deal Tests Defense Strength Versus 737 MAX Setbacks

Boeing (NYSE:BA) has secured a new $289 million contract to supply up to 5,000 precision guided bombs to Israel. The deal arrives as Boeing faces fresh delivery delays tied to 737 MAX wiring issues in its commercial aircraft segment. This order adds to Boeing's defense backlog at a time when investors are closely watching the split between its military and commercial businesses. Boeing shares recently closed at $204.76, with the stock down 7.8% over the past week and 15.6% over the past...
NasdaqGS:FRME
NasdaqGS:FRMEBanks

Assessing First Merchants (FRME) Valuation After Recent Share Price Weakness

If you are wondering whether First Merchants at around US$36.55 is offering good value today, you are not alone. This article will walk through what the current price may be implying. The stock has seen mixed returns, with a 5.2% decline over the last 7 days and a 12.5% decline over the last 30 days, while the 3 year return sits at 11.9% and the 1 year return at a 2.9% decline. Recent trading moves have put more attention on how investors are pricing regional banks like First Merchants and...
NYSE:FN
NYSE:FNElectronic

Assessing Fabrinet (FN) Valuation After Recent Share Price Pullback And Strong Multi Year Returns

Why Fabrinet is on investors’ radar today Fabrinet (FN) is drawing investor interest after recent trading, with the share price at US$512.80 and mixed short term returns, including a 2.2% decline over the past day and 5.8% over the past week. See our latest analysis for Fabrinet. That 2.2% one day and 5.8% seven day share price pullback comes after a 10% 30 day share price return and a very large 1 year total shareholder return. As a result, the recent weakness looks more like a pause than a...
NYSE:NUE
NYSE:NUEMetals and Mining

Nucor Commercial Chief Retirement Puts Succession And Pricing Discipline In Focus

Nucor Corporation (NYSE:NUE) announced that Executive Vice President of Commercial, Daniel R. Needham, plans to retire after a long tenure with the company. His retirement marks the departure of a senior leader who has held a key commercial role within Nucor. The company has described this as a planned transition, giving stakeholders time to assess potential implications for commercial operations and leadership continuity. Nucor, a major US steel producer, operates at the center of sectors...
NYSE:ATEN
NYSE:ATENSoftware

A Look At A10 Networks (ATEN) Valuation After Fresh Optimism On AI Security Demand

A10 Networks (ATEN) is back in focus after a research firm highlighted what it sees as strong demand for the company’s network security products tied to AI infrastructure, surging traffic, and expanding customer data centers. See our latest analysis for A10 Networks. The latest AI related enthusiasm comes after a period of steady gains, with the share price at US$21.06 and a 90 day share price return of 16.23%, while the 5 year total shareholder return of 125.84% points to sustained investor...
NasdaqGS:PGEN
NasdaqGS:PGENBiotechs

Is Precigen (PGEN) Reflecting Its Recent Surge Despite Steep Short Term Pullback

If you are trying to figure out whether Precigen's current share price reflects its underlying value, you are not alone. This article is built to walk you through that question step by step. The stock last closed at US$3.28, with returns of 88.5% over 1 year and 203.7% over 3 years, but also a 29.6% decline over 30 days and a 23.4% decline year to date. These moves can change how investors think about both potential and risk. Recent company updates and sector news have kept Precigen on many...
NYSE:FUN
NYSE:FUNHospitality

Is It Time To Reassess Six Flags Entertainment (FUN) After Its Prolonged Share Price Slump?

If you are wondering whether Six Flags Entertainment is a bargain or a value trap at around US$15.57 per share, this article walks through what the numbers actually say about the stock's current price. The share price is roughly flat year to date with a 0.5% return, but the stock has seen a 11.1% decline over the last 7 days, a 13.8% decline over the last 30 days, and a 55.6% decline over the past year, along with a 64.0% and 67.0% decline over the last 3 and 5 years respectively, which is...
NasdaqGS:HALO
NasdaqGS:HALOBiotechs

Halozyme Therapeutics (HALO) Valuation Check After Recent Share Price Pullback

Why Halozyme Therapeutics (HALO) is on investors’ radar today Recent trading in Halozyme Therapeutics (HALO) has drawn attention, with the stock down around 4% over the past day and about 6% over the past week, prompting investors to reassess its current pricing. See our latest analysis for Halozyme Therapeutics. At a share price of US$63.56, Halozyme’s recent 1 month share price decline of about 21% contrasts with a positive 3 month share price return of roughly 2% and a 1 year total...
NYSE:XYZ
NYSE:XYZDiversified Financial

Block Reshapes Cost Base With AI Cuts And Stablecoin Push

Block (NYSE:XYZ) is cutting roughly 40% of its workforce as it rolls out an AI powered payment flow across its platforms. The company is tying these reductions directly to wider use of agentic AI in its operations and product experience. Block is also starting to support stablecoins within Cash App, a shift from its earlier stance on these digital assets. Block runs a broad payments and financial services ecosystem, with Cash App, Square and other tools serving consumers and merchants. The...
NYSE:VLO
NYSE:VLOOil and Gas

A Look At Valero Energy’s Valuation As Earnings Beat And Dividend Hike Fuel Investor Enthusiasm

Valero Energy (VLO) is back in focus after reporting better than expected Q4 2025 earnings, paired with a dividend increase and a heavier 2026 capex plan that signals management confidence in cash generation. See our latest analysis for Valero Energy. Those earnings and the richer dividend sit alongside a sharp shift in market sentiment, with a 30 day share price return of 18.20% and a 1 year total shareholder return of 92.96%. This suggests strong recent momentum on top of already solid...
NasdaqGS:SIRI
NasdaqGS:SIRIMedia

A Look At Sirius XM (SIRI) Valuation After Recent Debt Refinancing And Lower Near Term Obligations

Debt refinancing puts Sirius XM Holdings (SIRI) capital structure in focus Sirius XM Holdings (SIRI) recently refinanced part of its balance sheet by issuing new 2032 notes and using the proceeds to retire about US$498.9 million of 3.125% Senior Notes due 2026. The company also satisfied and discharged the remaining 2026 note obligations by depositing US treasuries with the trustee, reducing near-term debt commitments and giving investors fresh information to assess its capital...
NasdaqGS:WBD
NasdaqGS:WBDEntertainment

Warner Bros. Discovery Layoffs Test Merger Integration And Lofty Valuation

Warner Bros. Discovery is initiating another round of layoffs across production, business affairs, and finance as part of its post merger integration with Paramount Skydance. The cuts come during an ongoing industry wide reset and follow earlier cost reduction efforts tied to combining the two media groups. These workforce changes raise fresh questions about organizational stability, corporate culture, and the company's capacity to meet its post merger content and integration goals. For...
NYSE:SXT
NYSE:SXTChemicals

Assessing Sensient Technologies (SXT) Valuation After Recent Share Price Softness And Long Term Rebound

Sensient Technologies (SXT) is back on investors’ radar after recent trading put the shares at $91.63, with the stock showing mixed short term returns but stronger performance over the past year and multi year period. See our latest analysis for Sensient Technologies. Short-term share price returns have softened, with a 1-month share price return of a 10.21% decline and a year-to-date share price return of a 1.94% decline. However, the 1-year total shareholder return of 28.34% points to...
NYSE:ET
NYSE:ETOil and Gas

Did Analyst Optimism on Projects and Valuation Just Shift Energy Transfer's (ET) Investment Narrative?

In recent days, analysts have reiterated generally positive views on Energy Transfer, highlighting its expanding pipeline and export network and expecting year-over-year growth in upcoming earnings and revenue. An interesting angle is how this mix of midstream project execution and comparatively low forward valuation metrics is shaping analyst expectations for the partnership’s future earnings profile. We’ll now examine how this fresh analyst optimism about upcoming earnings growth might...
NasdaqGS:TER
NasdaqGS:TERSemiconductor

Is It Too Late To Reassess Teradyne (TER) After Its 237% One Year Surge

If you are wondering whether Teradyne's current share price still reflects good value, you are not alone. The stock has drawn a lot of attention from investors trying to work out what is already priced in. After a strong longer term run, including a 38.1% gain year to date and a 237.1% return over the past year, the share price has recently eased back, with a 6.2% decline over the last week and a 6.0% decline over the past month. These recent moves sit against a backdrop of ongoing interest...
NasdaqGS:DUOL
NasdaqGS:DUOLConsumer Services

Is Duolingo (DUOL) Rewriting Its Long-Term Story By Sacrificing Margins For User Growth?

In recent months, Duolingo announced it would invest more heavily in artificial intelligence and user acquisition, accepting slower earnings growth and narrower margins in the near term to accelerate expansion and nearly double daily active users by 2028. This shift toward prioritizing user growth has already drawn legal scrutiny and amplified debate over how much short-term profitability investors are willing to trade for longer-term scale. We’ll now examine how Duolingo’s choice to...
NYSE:HG
NYSE:HGInsurance

Do Hamilton’s New Underwriting Leaders Reshape HG’s Strategic Edge In Specialty Reinsurance?

Hamilton Insurance Group recently reshaped leadership at its London-based Hamilton Global Specialty unit, appointing long-time executive Sinead Cormican as Chief Underwriting Officer while she continues as Active Underwriter of Syndicate 4000, and expanding Richard Northcott’s responsibilities to include Head of Business Development Strategy alongside Marine and Energy. These changes follow a quarter in which Hamilton reported a 27.7% year-on-year revenue increase and the largest analyst...
NYSE:WFC
NYSE:WFCBanks

Assessing Wells Fargo (WFC) Valuation As WFUSD Trademark Marks A Push Into Digital Assets

Trending interest in Wells Fargo (WFC) is being driven by its trademark filing for WFUSD, a planned digital asset platform tied to cryptocurrency payments, tokenized assets, and blockchain based trading services. See our latest analysis for Wells Fargo. The latest WFUSD filing and a series of recent fixed income offerings come at a time when Wells Fargo’s share price has seen an 18.1% 30-day decline and a 21.0% year-to-date share price loss, even though the 5-year total shareholder return is...
NYSE:CB
NYSE:CBInsurance

US-Backed Hormuz Shipping Reinsurance Backstop Could Be A Game Changer For Chubb (CB)

Earlier in March 2026, Chubb Limited agreed to act as lead underwriter for a US government-backed maritime reinsurance program providing up to US$20.00 billion of rolling coverage for vessels transiting the conflict-affected Strait of Hormuz, aiming to restore shipping activity disrupted by war risk insurance withdrawals. This move underscores Chubb’s role as a key risk carrier for critical global trade routes and highlights the company’s operational capacity, balance sheet strength, and...
NasdaqGS:QURE
NasdaqGS:QUREBiotechs

Why uniQure (QURE) Is Up 59.1% After FDA Oversight Shift and AMT-130 Analyst Upgrades – And What's Next

In early March 2026, uniQure reported full-year 2025 results showing revenue of US$16.1 million and a net loss of US$198.97 million, while also facing multiple securities class action lawsuits over alleged misstatements about FDA interactions for its AMT-130 Huntington’s disease gene therapy. At the same time, sentiment around uniQure has shifted as several banks upgraded the stock after news that the FDA official overseeing AMT-130 will step down, raising questions about how a possible...